SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-026866
Filing Date
2024-03-06
Accepted
2024-03-06 07:09:43
Documents
88
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K itos-20231231.htm   iXBRL 10-K 2941276
2 EX-21.1 itos-ex21_1.htm EX-21.1 7823
3 EX-23.1 itos-ex23_1.htm EX-23.1 3469
4 EX-31.1 itos-ex31_1.htm EX-31.1 15306
5 EX-31.2 itos-ex31_2.htm EX-31.2 15352
6 EX-32.1 itos-ex32_1.htm EX-32.1 9898
7 EX-32.2 itos-ex32_2.htm EX-32.2 10700
8 EX-97.1 itos-ex97_1.htm EX-97.1 42784
9 GRAPHIC img164189564_0.jpg GRAPHIC 121580
10 GRAPHIC img164189564_1.jpg GRAPHIC 184660
11 GRAPHIC img164189564_2.jpg GRAPHIC 148757
12 GRAPHIC img164189564_3.jpg GRAPHIC 73092
13 GRAPHIC img164189564_4.jpg GRAPHIC 63263
  Complete submission text file 0000950170-24-026866.txt   13010168

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itos-20231231.xsd EX-101.SCH 1620920
90 EXTRACTED XBRL INSTANCE DOCUMENT itos-20231231_htm.xml XML 1993282
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39401 | Film No.: 24724351
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)